tVNS and heart disease

Neuronium
06/27/2024
last update27 June 2024

tVNS Shows Potential Benefits for Heart Disease Based on the provided search results, here are the key points regarding the use of transcutaneous vagus nerve stimulation (tVNS) for heart disease:

[1] A study found that tVNS decreased autonomic dysfunction and the risk of chronic cardiovascular disease, suggesting potential benefits for heart disease.

[2] A clinical trial (NCT05789147) is currently investigating the effects of 6-month tVNS (1 hour/day) on autonomic biomarkers in heart failure patients with preserved or midrange ejection fraction. The trial aims to evaluate the potential of tVNS as a treatment for heart failure.

[3] In a study on heart failure patients, tVNS was associated with reduced afterload, which is beneficial for cardiac function. The proposed mechanisms include suppression of sympathetic nervous system activity, anti-inflammatory effects, and improved baroreflex sensitivity.

Potential Mechanisms of tVNS in Heart Disease

[3][4] tVNS may reduce sympathetic outflow and increase parasympathetic activity, which can be beneficial in conditions like heart failure characterized by autonomic imbalance. The proposed mechanisms include:

– Suppression of central sympathetic nervous system outflow
– Anti-inflammatory effects
– Improved baroreflex sensitivity
– Activation of nitric oxide release in the heart
– Inhibition of the renin-angiotensin system

However, the effects of tVNS may vary depending on factors like stimulation parameters, disease background, and patient characteristics.[3]

In summary, while the evidence is still limited, the provided search results suggest that tVNS has potential therapeutic benefits for heart disease, particularly heart failure, through modulation of autonomic function and various cardioprotective mechanisms.

Sources